Literature DB >> 9379137

Integrin function in osteoclasts.

S B Rodan1, G A Rodan.   

Abstract

Integrins are a large family of heteromeric cell surface receptors composed of non-covalently bound alpha and beta subunits which interact with extracellular matrix molecules, serum constituents and the adhesion molecules of the immunoglobulin family. The extracellular domains of many integrins recognize the RGD (Arg-Gly-Asp) tripeptide found in several extracellular macromolecules such as fibronectin, vitronectin, fibrinogen and osteopontin. The vitronectin receptor, alpha v beta 3 integrin, is highly expressed in osteoclasts, the bone resorbing cells, and binds many of these RGD containing proteins including osteopontin, which is abundant in bone. Antibodies to alpha v beta 3, RGD peptides and RGD containing proteins such as echistatin, and kistrin were shown to inhibit bone resorption in vitro and in vivo. The identity of the alpha v beta 3 natural ligand and its mode of action in bone are so far not known. In addition to the very high levels of alpha v beta 3, mammalian osteoclasts also express alpha 2 beta 1, a collagen/laminin receptor and alpha v beta 1, another vitronectin receptor. Signaling events that follow substrate recognition by osteoclasts are not well understood. RGD containing peptides and proteins modulate [Ca2+] transients in osteoclasts and phosphatidylinositol 3-kinase and pp60c-src are associated with alpha v beta 3 in these cells. alpha v and beta 3 genes were shown to be regulated by the calciotropic hormone 1,25(OH)2D3 and by a number of cytokines known to be modulators of bone metabolism. In summary, elucidation of the interactions of osteoclast integrins with components of bone matrix, may lead to further understanding of the mechanism of bone resorption.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379137

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  26 in total

Review 1.  Regulation of osteoclast formation and function.

Authors:  L T Duong; G A Rodan
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium.

Authors:  Deborah A Bradley; Stephanie Daignault; Charles J Ryan; Robert S Dipaola; Kathleen A Cooney; David C Smith; Eric Small; Paul Mathew; Mitchell E Gross; Mark N Stein; Alice Chen; Kenneth J Pienta; June Escara-Wilke; Gerald Doyle; Mahmoud Al-Hawary; Evan T Keller; Maha Hussain
Journal:  Invest New Drugs       Date:  2010-03-25       Impact factor: 3.850

3.  [Serum-free cultivation of osteoprogenitor cells and osteoblasts to test biomaterials].

Authors:  N Duewelhenke; P Eysel
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

4.  Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption.

Authors:  H Yoshitake; S R Rittling; D T Denhardt; M Noda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

5.  The type II collagen N-propeptide, PIIBNP, inhibits cell survival and bone resorption of osteoclasts via integrin-mediated signaling.

Authors:  Shinya Hayashi; Zhepeng Wang; Jennifer Bryan; Chikashi Kobayashi; Roberta Faccio; Linda J Sandell
Journal:  Bone       Date:  2011-06-25       Impact factor: 4.398

6.  Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.

Authors:  Mari Okayasu; Mai Nakayachi; Chiyomi Hayashida; Junta Ito; Toshio Kaneda; Masaaki Masuhara; Naoto Suda; Takuya Sato; Yoshiyuki Hakeda
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

Review 7.  An odyssey from breast to bone: multi-step control of mammary metastases and osteolysis by matrix metalloproteinases.

Authors:  A Lochter; M J Bissell
Journal:  APMIS       Date:  1999-01       Impact factor: 3.205

8.  Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma.

Authors:  Huan Liu; Zhiqiang Liu; Juan Du; Jin He; Pei Lin; Behrang Amini; Michael W Starbuck; Nora Novane; Jatin J Shah; Richard E Davis; Jian Hou; Robert F Gagel; Jing Yang
Journal:  Sci Transl Med       Date:  2016-08-24       Impact factor: 17.956

9.  Forkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expression.

Authors:  Dmitriy Malin; Il-Man Kim; Evan Boetticher; Tanya V Kalin; Sneha Ramakrishna; Lucille Meliton; Vladimir Ustiyan; Xiangdong Zhu; Vladimir V Kalinichenko
Journal:  Mol Cell Biol       Date:  2007-01-29       Impact factor: 4.272

10.  The influence of surface mineral and osteopontin on the formation and function of murine bone marrow-derived osteoclasts.

Authors:  Rupak M Rajachar; Anh Q Truong; Cecilia M Giachelli
Journal:  J Mater Sci Mater Med       Date:  2008-05-16       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.